Clinical trials
Completed Hyperkalemia trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Portsmouth Hospitals NHS Trust | 1 |
| Relypsa, Inc. | 1 |
| St George's, University of London | 1 |
| Vifor (International) Inc. | 1 |
| Vifor Pharma, Inc. | 1 |
| ZS Pharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperkalemia | 10 |
| Renal Insufficiency, Chronic | 5 |
| Heart Failure | 3 |
| Hypertension | 2 |
| Acute Kidney Injury | 1 |
| Pseudohypoaldosteronism | 1 |
| Ventricular Dysfunction, Left | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.